EUCTR2008-004486-26-IT进行中（未招募）不适用
Efficacy of monoclonal anti CD 20 antibodies in steroid and cyclosporin dependent nephrotic syndrome in children - ND
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Age between 1-16 years 2-clinical picture of idiopathic nephrotic syndrome
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Positicity of autoantibodies and low levels of C3
研究者
相似试验
尚未招募
2 期
Treatment of elderly patients with ischemic strokeElderly patients with ischemic stroke.Ischemic StrokeIRCT20160422027520N11Tabriz University of Medical Sciences12
进行中（未招募）
1 期
Efficacy of Ofatumumab in children with steroid-dependent nephrotic syndrome aEUCTR2018-001042-33-ITIRCCS Istituto Giannina Gaslini160
已完成
2 期
Rescue treatment with the monoclonal anti CD20-antibody Obinutuzumab (GA101) in combination with PixantrOne for the treatment of patients with relapsed Aggressive B-cell LymphomaDiffuse large B-cell lymphomaC83.3C82.4C85.1Follicular lymphoma grade IIIbB-cell lymphoma, unspecifiedDRKS00009416niversitätsmedizin der Johannes Gutenberg-Universität Mainz70
已完成
不适用
Anti-CD20 monoclonal antibody therapy for type II mixed cryoglobulinemia syndromeMixed cryoglobulinemia HCV- related or unrelatedHaematological DisordersCryoglobulinaemiaISRCTN55287110niversity of Udine (Italy)124
招募中
4 期
Anti-CD20 Antibodies for Treatment of SLE-PAHSystemic Lupus ErythematosusPulmonary Arterial HypertensionNCT05828147Chinese SLE Treatment And Research Group50